| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5521114 | Drug Discovery Today | 2016 | 16 Pages |
â¢Modern drug discovery efforts are leaning toward natural product-based scaffolds.â¢Marine natural products exemplify novel resources for new drugs.â¢Marine organisms offer architecturally complex and unique structural features.â¢Several MNPs can effectively target cancer cell migration and invasion.
The marine environment is a reliable source for the discovery of novel treatment options for numerous diseases. Past research efforts toward the discovery of marine-derived anticancer agents have resulted in several commercially available marine-based drugs. The pharmaceutical value of anticancer drugs from marine natural products (MNPs) ranges from US$563 billion to US$5.69 trillion. In this review, we highlight several marine-derived entities with the potential for cancer control and prevention through the inhibition of crucial tumor cell motility and/or migration steps involved in subsequent cancer metastases. This report also covers the major hurdles typically faced by the MNPs research scientific community.
Graphical abstractDownload high-res image (327KB)Download full-size image
